Biohaven Ltd. (BHVN) is a publicly traded Healthcare sector company. As of July 9, 2026, BHVN trades at $16.78 with a market cap of $2.34B and a P/E ratio of -1.09. BHVN moved +9.08% today. Year to date, BHVN is +47.39%; over the trailing twelve months it is +19.37%. Its 52-week range spans $7.48 to $49.56. Analyst consensus is buy with an average price target of $17.70. Rallies surfaces BHVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BHVN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $16.78 |
| Market Cap | $2.34B |
| P/E Ratio | -1.09 |
| EPS | $-14.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.56 |
| 52-Week Low | $7.48 |
| Volume | 2.93M |
| Avg Volume | 0 |
| Revenue (TTM) | $859.68M |
| Net Income | $-930.69M |
| Gross Margin | 85.63% |
13 analysts cover BHVN: 0 strong buy, 8 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.70.